Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
4.29B | 3.63B | 3.15B | 2.55B | 2.13B | Gross Profit |
2.39B | 1.83B | 1.61B | 1.37B | 1.10B | EBIT |
927.51M | 652.75M | 564.71M | 504.20M | 338.13M | EBITDA |
1.04B | 719.53M | 611.15M | 548.81M | 384.82M | Net Income Common Stockholders |
759.56M | 516.82M | 451.95M | 382.57M | 276.14M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.50B | 981.79M | 843.53M | 1.09B | 649.44M | Total Assets |
3.14B | 2.56B | 2.33B | 2.17B | 1.77B | Total Debt |
266.88M | 246.49M | 222.07M | 223.04M | 295.72M | Net Debt |
-1.24B | -735.31M | -621.46M | -866.32M | -353.72M | Total Liabilities |
1.03B | 790.47M | 793.42M | 723.48M | 625.00M | Stockholders Equity |
2.11B | 1.77B | 1.54B | 1.44B | 1.14B |
Cash Flow | Free Cash Flow | |||
943.82M | 456.40M | 121.34M | 564.00M | 253.88M | Operating Cash Flow |
1.03B | 537.42M | 172.35M | 596.22M | 286.33M | Investing Cash Flow |
-89.33M | -81.01M | -51.01M | -32.17M | -31.96M | Financing Cash Flow |
-417.68M | -309.03M | -367.48M | -129.58M | -192.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | $16.57B | 17.72 | 39.80% | ― | 19.40% | 32.70% | |
77 Outperform | $5.39B | 6.02 | 57.76% | ― | 3.53% | 24.55% | |
75 Outperform | $9.65B | 40.68 | 8.52% | ― | 20.40% | 134.09% | |
73 Outperform | $7.44B | 11.92 | 14.67% | ― | 10.66% | 9.44% | |
70 Outperform | $1.52B | 8.89 | 20.20% | 4.04% | 15.03% | 1.51% | |
61 Neutral | $1.05B | 22.43 | 15.57% | 3.14% | -21.75% | ― | |
60 Neutral | $6.87B | 11.73 | 3.11% | 4.16% | 2.36% | -22.03% |